Managing the COVID-19 health crisis: a survey of Swiss hospital pharmacies.
COVID-19
Disasters
Health facilities
Hospital
Lessons learned
Pandemics
Pharmacy service
Response
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
20 Oct 2023
20 Oct 2023
Historique:
received:
09
03
2023
accepted:
03
10
2023
medline:
2
11
2023
pubmed:
21
10
2023
entrez:
20
10
2023
Statut:
epublish
Résumé
The COVID-19 pandemic strained healthcare systems immensely as of 2020. Switzerland's hospital pharmacies' responses during the first wave were surveyed with a view to improving the quality of pharmaceutical management in future health crises. An online survey was sent to the heads of all of Switzerland's hospital pharmacies. The questionnaire was organised into eleven sections of questions covering many topics regarding the management of COVID-19's first wave. Data collection occurred from May to June 2020. Analyses were performed using the 43 questionnaires (66%), with at least one answer per questionnaire, out of 65 distributed. Seventeen of 41 pharmacies responding (41%) had existing standard operating procedures or pandemic plans and 95% of these (39/41) set up crisis management steering committees. Twenty-nine of 43 pharmacies responding (67%) created new activities to respond to the pandemic's specific needs. Twenty-six of 39 pharmacies responding (67%) created new drug lists for: COVID-19-specific treatments (85%; 22/26), sedatives (81%; 21/26), anaesthetics (77%; 20/26) and antibiotics (73%; 19/26). Drug availability in designated COVID-19 wards was managed by increasing existing stocks (54%; 22/41 pharmacies) and creating extra storage space (51%; 21/41). Two drugs generated the greatest concern about shortages: propofol (49%; 19/39 pharmacies) and midazolam (44%; 17/39). Remdesivir stocks ran out in 26% of pharmacies (10/39). Twelve of 43 pharmacies (28%) drafted specific new documents to respond to medical needs regarding drug administration, 12 (28%) did so for drug preparation and 10 (23%) did so for treatment choices. Switzerland's hospital pharmacies encountered many challenges related to the COVID-19 crisis and had to find solutions quickly, effectively and safely. The survey highlighted the key role that hospital pharmacies played in many aspects of the pandemic by providing logistical and clinical support to medical and nursing care teams. The lessons and experiences outlined could be used to improve the quality of hospital pharmacies' readiness for similar future events.
Sections du résumé
BACKGROUND
BACKGROUND
The COVID-19 pandemic strained healthcare systems immensely as of 2020. Switzerland's hospital pharmacies' responses during the first wave were surveyed with a view to improving the quality of pharmaceutical management in future health crises.
METHODS
METHODS
An online survey was sent to the heads of all of Switzerland's hospital pharmacies. The questionnaire was organised into eleven sections of questions covering many topics regarding the management of COVID-19's first wave. Data collection occurred from May to June 2020.
RESULTS
RESULTS
Analyses were performed using the 43 questionnaires (66%), with at least one answer per questionnaire, out of 65 distributed. Seventeen of 41 pharmacies responding (41%) had existing standard operating procedures or pandemic plans and 95% of these (39/41) set up crisis management steering committees. Twenty-nine of 43 pharmacies responding (67%) created new activities to respond to the pandemic's specific needs. Twenty-six of 39 pharmacies responding (67%) created new drug lists for: COVID-19-specific treatments (85%; 22/26), sedatives (81%; 21/26), anaesthetics (77%; 20/26) and antibiotics (73%; 19/26). Drug availability in designated COVID-19 wards was managed by increasing existing stocks (54%; 22/41 pharmacies) and creating extra storage space (51%; 21/41). Two drugs generated the greatest concern about shortages: propofol (49%; 19/39 pharmacies) and midazolam (44%; 17/39). Remdesivir stocks ran out in 26% of pharmacies (10/39). Twelve of 43 pharmacies (28%) drafted specific new documents to respond to medical needs regarding drug administration, 12 (28%) did so for drug preparation and 10 (23%) did so for treatment choices.
CONCLUSIONS
CONCLUSIONS
Switzerland's hospital pharmacies encountered many challenges related to the COVID-19 crisis and had to find solutions quickly, effectively and safely. The survey highlighted the key role that hospital pharmacies played in many aspects of the pandemic by providing logistical and clinical support to medical and nursing care teams. The lessons and experiences outlined could be used to improve the quality of hospital pharmacies' readiness for similar future events.
Identifiants
pubmed: 37864155
doi: 10.1186/s12913-023-10105-6
pii: 10.1186/s12913-023-10105-6
pmc: PMC10589985
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1134Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Disasters. 2008 Mar;32(1):41-65
pubmed: 18217917
Am J Health Syst Pharm. 2020 Sep 4;77(18):1510-1515
pubmed: 34279575
Res Social Adm Pharm. 2021 Jan;17(1):1946-1949
pubmed: 32446652
Pharmacy (Basel). 2021 Aug 19;9(3):
pubmed: 34449721
Am J Health Syst Pharm. 2005 Nov 1;62(21):2202, 4, 9,16
pubmed: 16239405
Am J Health Syst Pharm. 2020 Nov 16;77(23):1986-1993
pubmed: 32417878
Pharmacy (Basel). 2020 Aug 07;8(3):
pubmed: 32784696
Res Social Adm Pharm. 2021 Jan;17(1):1990-1996
pubmed: 33189602
Am J Health Syst Pharm. 2021 Mar 31;78(8):705-711
pubmed: 33506860
Prehosp Disaster Med. 2019 Feb;34(1):30-37
pubmed: 30604658
Disaster Med Public Health Prep. 2013 Dec;7(6):563-72
pubmed: 24112433
Res Social Adm Pharm. 2021 Jan;17(1):1799-1806
pubmed: 33317760
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Am J Health Syst Pharm. 2020 Jul 23;77(15):1191-1194
pubmed: 32407517
J Infect. 2020 Apr;80(4):373-377
pubmed: 32109444
J Pharm Pract. 2014 Aug;27(4):350-7
pubmed: 24128786
Am J Health Syst Pharm. 2020 Jul 7;77(14):1096-1097
pubmed: 32399549
Res Social Adm Pharm. 2021 Aug;17(8):1507-1517
pubmed: 33288420
BMC Health Serv Res. 2022 Jul 2;22(1):853
pubmed: 35780151
Prehosp Disaster Med. 2006 Jan-Feb;21(1):24-30
pubmed: 16602262
Int J Pharm Pract. 2021 Feb 10;29(1):12-20
pubmed: 32881173
J Nepal Health Res Counc. 2020 Apr 20;18(1):142-143
pubmed: 32335611